Masayuki Nakao

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer

Rie Sakakibara, Kentaro Inamura, Yuichi Tambo et al. · Clinical Lung Cancer · 2016 · 127 citations

Medicine, Promising Method, Tumor Pd-l1 Expression +9

Differences Between Squamous Cell Carcinoma and Adenocarcinoma of the Lung: Are Adenocarcinoma and Squamous Cell Carcinoma Prognostically Equal?

Akikazu Kawase, Junji Yoshida, G. Ishii et al. · Japanese Journal of Clinical Oncology · 2011 · 117 citations · Full text

Long-Term Outcomes of 50 Cases of Limited-Resection Trial for Pulmonary Ground-Glass Opacity Nodules

Masayuki Nakao, Junji Yoshida, Kōichi Goto et al. · Journal of Thoracic Oncology · 2012 · 93 citations · Full text

Medical Imaging, Advanced Lung Disease, Multiple Pulmonary Nodule +8

Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56

Rie Sakakibara, Maki Kobayashi, Naoko Takahashi et al. · The American Journal of Surgical Pathology · 2020 · 76 citations

A Novel Histopathological Evaluation Method Predicting the Outcome of Non-small Cell Lung Cancer Treated by Neoadjuvant Therapy: The Prognostic Importance of the Area of Residual Tumor

Yuki Yamane, Genichiro Ishii, Kōichi Goto et al. · Journal of Thoracic Oncology · 2010 · 65 citations · Full text

Residual Tumor, Neoadjuvant Therapy, Medicine +15